Cancer has forced me into this reckoning. First through my advocacy activities, which are mostly collaborations, but also simply through experiencing nearly ...

Omitting surgery after receiving initial treatment with systemic therapy offered positive results for patients with invasive forms of breast cancer, ...

The future of cancer treatment has never been more exciting.  A third of new medicines being developed are cancer treatments, and a significant number ...

The evaluation of Annamycin in combination with Ara-C (cytarabine) has launched in a new Phase 1B/2 trial, called MB-106, for patients with acute myeloid ...

Patients with metastatic pancreatic ductal adenocarcinoma responded to treatment with onvansertib in combination with standard of care, as demonstrated in ...

I’ve never had a reason to examine mortality, not mine or others, it was just there. Our parents have long since passed, grieving surfaced briefly, however, ...

The U.S. Food and Drug Administration (FDA) has released a new fast track designation for IDE161, an inhibitor of poly (ADP-ribose) glycohydrolase (PARG) to ...

Patients with metastatic pancreatic ductal adenocarcinoma (mPDAC) treated with the NALIRIFOX regimen of Onivyde (irinotecan liposome injection) plus ...

Sometimes, I forget I had cancer. That seems a strange thing to say, but it’s true. It’s been almost 10 years since I was diagnosed with breast cancer. It ...

Patients with relapsed/refractory multiple myeloma benefited from treatment with MCARH109, a CAR-T cell therapy targeting the “enigmatic” GPRC5D antigen ...

Among patients with squamous cell head and neck carcinoma, oral microbiome is associated with severity of oral mucositis (OM), an after-effect of ...

Treatment with Tecvayli (teclistamab-cqyv) for real-world patients with relapsed/refractory multiple myeloma demonstrated similar efficacy results and a ...